Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in PCSK9 Inhibitors
by Most News Heat in the Netherlands in 2022

The PCSK9 Inhibitors top 5 is Discovery PatSnap’ annual ranking of the top 5 Most News Heat PCSK9 Inhibitors Key Players in the Netherlands. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
The PCSK9 inhibitors are a class of injectable drugs approved in 2015 that have been shown to dramatically lower LDL cholesterol levels -- by up to 60% in some cases -- when combined with a statin.. PCSK9 inhibitors are monoclonal antibodies (MABs), a type of biologic drug. They bind to and inactivate an enzyme in the liver called proprotein convertase subtilisin kexin 9 (PCSK9).
#
Company Name
Region
Tech Topics
Total
1
Organon & Co.
Herb,Botanical drug
news: 4
2
GeoJunxion NV
Software,Automotive engineering,Navigation system,
...[+2]
news: 2
3
Forbion Capital Partners Management Holding BV
Venture capital,Health care,Academic institution,
...[+2]
news: 1
4
Leids Universitair Medisch Centrum
Medical research,Hospitality industry,Health care,
...[+2]
news: 1
5
NewAmsterdam Pharma BV
Biology
news: 1
Page generation time: Jun 03 2025